Schizophrenia could also be a context for implementing these immunometabolic strategies ( Previous clinical observations indicate that a rapid and substantial reduction in body mass may result in significant mental disturbances
Become a member Already a member
Pablo de la Cueva ha participado como asesor y/o investigador y/o ponente con los siguientes laboratorios farmacuticos: Abbvie, Almirall, BMS, Boehringer-Ingelheim, Celgene, Janssen Cilag, LEO Pharma, Lilly, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi y UCB
Use recent records: stale weights or old labs can trigger delays Match the diagnosis to the request: coding and chart wording should point in the same direction Document failed or insufficient response clearly: vague phrases like tried diet dont help much Prepare for renewal early: if ongoing treatment later requires proof of response, your follow-up notes should already capture progress A good file doesnt exaggerate
Cummings discussed the evidence for the medications, which, despite their relative infancy, he has prescribed to more than 1,000 patients